Childhood immunisation statistics Scotland
Quarter ending 30 June 2024

About this release

This release by Public Health Scotland (PHS) provides a quarterly update of immunisation uptake rates for children in Scotland. Immunisation programmes for children aim to protect the individual child from many serious infectious diseases and prevent the spread of disease in the wider population. Advice on why and when to immunise in Scotland is available via NHS inform. Information is shown for NHS Boards and local authorities, at 12 months, 24 months, 5 years and 6 years of age.

Main points

• Quarterly uptake rates in Scotland have gradually declined over time. However, in the latest quarter ending June 2024, there have been small increases in levels of protection for children aged 24 months, 5 and 6 years old, compared with the previous quarter.
• Uptake for children aged 12 months old was: Pneumococcal Conjugate Vaccine (PCV) (95.1%), 6-in-1 (94.2%), MenB (93.8%), Rotavirus (92.1%).

A line chart showing percentage uptake of 6-in-1, MenB, PCV and Rotavirus immunisations separately by 12 months of age and by quarter, from quarter ending June 2015 to quarter ending June 2024. Details are provided in the accompanying text.

Close

Trend in primary immunisation uptake rates by 12 months of age*, by quarter

Children turning 12 months of age in the relevant quarter e.g. for Apr-Jun 24 this would be children born during Apr-Jun 23

• Most children received their booster vaccines by 24 months of age: Hib/MenC (93.2%), Pneumococcal Conjugate Vaccine (PCV) (93.0%) and MenB (92.6%).
• The first dose of MMR vaccine is offered between 12 and 13 months old and the second dose at 3 years 4 months old.
  • 92.8% of children had the first dose of MMR vaccine by 24 months of age. This rose to 95.8% for children who had reached age 5.
  • Uptake of the second dose of MMR vaccine by 5 years was 89.4%, rising to 91.1% by age 6 years.
• The 4-in-1 vaccine provides the booster dose (4th dose) of protection against diphtheria, tetanus, pertussis and polio. 90.0% of children had the 4-in-1 booster at age 5 years, rising to 91.8% by age 6 years.

Background

As a public health measure, immunisations are very effective in reducing the burden of disease. The European Region of the World Health Organization (WHO) recommends that on a national basis at least 95% of children are immunised against diseases preventable by immunisation and targeted for elimination or control. These include diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type b (Hib), measles, mumps and rubella.

Rotavirus vaccine should be given within strict age limits, with the first dose before 15 weeks and second dose before 24 weeks of age. These age limits mean that if a child is not immunised with the first dose early enough, due to missed appointments for example, then it may not be possible for them to complete the full 2 dose course before 24 weeks. This explains why uptake of the completed 2 dose course of rotavirus vaccine is slightly lower than completed courses of the other vaccines offered in the first year of life.

Further information

The next release of this publication will be December 2024.